Clinical Trial Update: Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating how filgotinib affects proteomic profiles and micro-RNA expression in patients with active rheumatoid arthritis, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Universita di Verona | Conditions: Rheumatoid Arthritis | Phase 4 | Status: RECRUITING